TP53 and exocrine pancreatic carcinoma: Although pulmonary carcinoma, mammary tumors, and pancreatic carcinomas are not over-represented in our canine-data set, TP53 is mutated in more than 25% of osteosarcoma in both species26, which represents 7% of tumor subtypes in this analysis.